15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Clearpoint Neuro Inc, 2 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $30.00 to $30.00, so the covering firms are broadly aligned. The average target of $30.00 sits 107% above the current $14.52. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.26 next quarter toward $-0.94 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Moderate Buy
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Clearpoint Neuro Inc.
As of Jul, 2 of 2 firms rate CLPT a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CLPT EPS & revenue forecast
EPS · NEXT QUARTER
$-0.26
Range $-0.31 – $-0.23 · 3 analysts · +25% YoY
Next period, 3 analysts expect Clearpoint Neuro Inc to earn $-0.26 a share (range $-0.31 – $-0.23), versus $-0.21 a year earlier. Full-year consensus is $-1.11, growing to $-0.94 the year after.
REVENUE · NEXT QUARTER
$13.6M
Range $13.4M – $13.9M · 3 analysts · +54% YoY
Revenue is expected to reach $13.6M (range $13.4M – $13.9M), +53.9% year-over-year. Full-year consensus is $53.1M, rising to $64.1M next year.
Top analysts covering Clearpoint Neuro Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CLPT.
#1
Frank Takkinen
Lake Street · Rank #327
Buy
$30.00+106.6% to target
Overall win rate
26%
+ Follow
#2
NC
Neil Chatterji
B. Riley Securities
Buy
$20.00+37.7% to target
Coverage
—
+ Follow
#3
AS
Anderson Schock
B. Riley Securities
Buy
$30.00+106.6% to target
Coverage
—
+ Follow
#4
MB
Mathew Blackman
Stifel
Buy
$25.00+72.2% to target
Coverage
—
+ Follow
CLPT stock forecast FAQ
What is CLPT's average 12-month price target?+
The 1 analysts with a live target average $30.00 for Clearpoint Neuro Inc over the next 12 months, ranging from a $30.00 high to a $30.00 low.
Is CLPT stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 2 analyst ratings, 2 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover CLPT?+
2 analysts have an active rating on Clearpoint Neuro Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering CLPT?+
Among analysts who currently cover CLPT, Frank Takkinen of Lake Street has the strongest overall Quantellect track record (Rank #327). Their current call is Buy with a $30.00 target.
What is Clearpoint Neuro Inc's projected EPS for next quarter?+
The consensus estimate is $-0.26 per share (range $-0.31 – $-0.23) across 3 analysts. Full-year EPS is projected at $-1.11, rising to $-0.94 the following year.
How much revenue is Clearpoint Neuro Inc expected to report next quarter?+
Consensus revenue is $13.6M (range $13.4M – $13.9M). Full-year revenue is projected at $53.1M, growing to $64.1M next year.
Have analysts been upgrading or downgrading CLPT lately?+
As of Jul, 2 of 2 firms rate CLPT a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CLPT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
